Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (85)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by GOODMAN, M. T.
Right arrow Articles by KOLONEL, L. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOODMAN, M. T.
Right arrow Articles by KOLONEL, L. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 131, No. 5: 815-825
Copyright © 1990 by The Johns Hopkins University School of Hygiene and Public Health


research-article

AGREEMENT BETWEEN INTERVIEW INFORMATION AND PHYSICIAN RECORDS ON HISTORY OF MENOPAUSAL ESTROGEN USE

MARC T. GOODMAN, ABRAHAM M. Y. NOMURA, LYNNE R. WILKENS and LAURENCE N. KOLONEL

Epidemiology Program, Cancer Research Center, University of Hawaii 1236 Lauhala Street, Suite 407, Honolulu, HI 96813

Reprint requests to Dr. Marc T. Goodman

A case-control study of the association between replacement estrogen use and breast cancer risk was conducted between 1975 and 1980 on Oahu, Hawaii. Data from this study were used to compare menopausal estrogen histories obtained through a personal interview with information from the subject's physician(s) or clinical records. The sample included 344 breast cancer cases, 344 hospital controls, and 344 neighborhood controls. Study participants included Japanese and white women aged 45–74 years who were residents of Oahu. Interviewers asked participants whether they had ever used replacement or menopausal estrogens for 1 month or longer. The month and year of initial use and the duration of use for each preparation were recorded for the users. Questions were also asked about a number of other medications. Information on estrogen use from the users and nonusers was then verified by the physician(s) or clinic(s) named by the study subject. The results showed moderate to substantial agreement between users and physicians on ever/never use of estrogens (kappa=0.74), duration of estrogen use (intraclass correlation coefficient (r1)=0.54), and age at initial use of estrogens r1=0.57). There was no differential misclassification by the case-control status of the subject Agreement tended to be better for Japanese subjects, younger subjects, nonsmokers, and those of higher socioeconomic status, as measured by two indicators, college education and home ownership. Agreement was also negatively influenced by the duration of estrogen use and length of recall. These results suggest that women can recall estrogen use with a high degree of accuracy and support the use of a personal interview for obtaining information on replacement estrogens in case-control studies.

breast neoplasms; epidemiologic methods; estrogens; interviews; memory; menopause; records


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. I. Li, K. E. Malone, P. L. Porter, T. J. Lawton, L. F. Voigt, K. L. Cushing-Haugen, M. G. Lin, X. Yuan, and J. R. Daling
Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J Public Health (Oxf)Home page
H. Fukuda and F. Shinsho
Accuracy of health examination results self-reported by Japanese participants
J. Public Health Med., September 1, 2007; 29(3): 316 - 320.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. A. Newcomb, Y. Zheng, V. M. Chia, L. M. Morimoto, V. P. Doria-Rose, A. Templeton, S. N. Thibodeau, and J. D. Potter
Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women
Cancer Res., August 1, 2007; 67(15): 7534 - 7539.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Shantakumar, M. B. Terry, A. Paykin, S. L. Teitelbaum, J. A. Britton, P. G. Moorman, S. B. Kritchevsky, A. I. Neugut, and M. D. Gammon
Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
Am. J. Epidemiol., May 15, 2007; 165(10): 1187 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
B. L. Strom, R. Schinnar, A. L. Weber, G. Bunin, J. A. Berlin, M. Baumgarten, A. DeMichele, S. C. Rubin, M. Berlin, A. B. Troxel, et al.
Case-Control Study of Postmenopausal Hormone Replacement Therapy and Endometrial Cancer
Am. J. Epidemiol., October 15, 2006; 164(8): 775 - 786.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. M. Boudreau, J. R. Daling, K. E. Malone, J. S. Gardner, D. K. Blough, and S. R. Heckbert
A Validation Study of Patient Interview Data and Pharmacy Records for Antihypertensive, Statin, and Antidepressant Medication Use among Older Women
Am. J. Epidemiol., February 1, 2004; 159(3): 308 - 317.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. I. Li, K. E. Malone, P. L. Porter, N. S. Weiss, M.-T. C. Tang, K. L. Cushing-Haugen, and J. R. Daling
Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
JAMA, June 25, 2003; 289(24): 3254 - 3263.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. A. Newcomb, L. Titus-Ernstoff, K. M. Egan, A. Trentham-Dietz, J. A. Baron, B. E. Storer, W. C. Willett, and M. J. Stampfer
Postmenopausal Estrogen and Progestin Use in Relation to Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 593 - 600.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. Lipworth, J. P Fryzek, C M. Fored, W. J Blot, and J. K McLaughlin
Comparison of surrogate with self-respondents regarding medical history and prior medication use
Int. J. Epidemiol., April 1, 2001; 30(2): 303 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Merlo, G. Berglund, E. Wirfalt, B. Gullberg, B. Hedblad, J. Manjer, B. Hovelius, L. Janzon, B. S. Hanson, and P. O. Ostergren
Self-administered Questionnaire Compared with a Personal Diary for Assessment of Current Use of Hormone Therapy: An Analysis of 16,060 Women
Am. J. Epidemiol., October 15, 2000; 152(8): 788 - 792.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. C. D. Westendorp, B. A. in't Veld, D. E. Grobbee, H. A. P. Pols, W. T. Meijer, A. Hofman, and J. C. M. Witteman
Hormone Replacement Therapy and Peripheral Arterial Disease: The Rotterdam Study
Arch Intern Med, September 11, 2000; 160(16): 2498 - 2502.
[Abstract] [Full Text]


Home page
StrokeHome page
I. C. D. Westendorp, B. A. I.’t Veld, M. L. Bots, J. M. Akkerhuis, A. Hofman, D. E. Grobbee, and J. C. M. Witteman
Hormone Replacement Therapy and Intima-Media Thickness of the Common Carotid Artery : The Rotterdam Study
Stroke, December 1, 1999; 30(12): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
L. B. Dunn, M. Damesyn, A. A. Moore, D. B. Reuben, and G. A. Greendale
Does Estrogen Prevent Skin Aging? Results From the First National Health and Nutrition Examination Survey (NHANES I)
Arch Dermatol, March 1, 1997; 133(3): 339 - 342.
[Abstract] [PDF]


Home page
JAMAHome page
D. Kritz-Silverstein and E. Barrett-Connor
Long-term Postmenopausal Hormone Use, Obesity, and Fat Distribution in Older Women
JAMA, January 3, 1996; 275(1): 46 - 49.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.